Wim has been the CEO of Methylomics (jul 2023 – jul 2025) and is now Chairman & Strategic Advisor. He received his PhD in genetics from the Erasmus University.
Wim oversees the primary processes, the acquisition of new projects and funding opportunities. He also manages collaborations with academic and industrial partners. He comes from an entrepreneurial family (DDL, LCPL, LBP, Brain Research Centre, Roosevelt Clinic).